# ShifAI - Next Steps & Strategic Decisions

**Date:** 2026-01-29  
**Status:** Post-Brief Produit, Pre-PRD  
**Agent Panel Review Score:** 8.6/10 (Mary: 9/10, John: 8.5/10, Sally: 9.5/10, Winston: 7.5/10)

---

## ‚úÖ Strategic Decisions Taken (Post-Agent Review)

### 1. ML Accuracy Strategy: **Hybrid Approach** ‚úÖ

**Decision:** Approche progressive Rule-based ‚Üí ML

**Phase 1 (Beta M1-3):**
- Predictions bas√©es sur **r√®gles heuristiques** (patterns classiques)
- Target accuracy: 60%+ (realistic, 20% better que Flo)
- Transparence: "ShifAI apprend TON rythme" (pas "70% garantie J1")

**Phase 2 (Launch M4-12):**
- ML progressif quand data suffisante (14+ jours historique)
- Target accuracy: 70%+ pour users avec historique
- Hybrid model: Rule-based pour nouveaux users, ML pour √©tablis

**Rationale (Winston):**
- Mitige risque technique ML cycles irr√©guliers
- Cold start problem r√©solu (r√®gles fonctionnent J1)
- ML s'am√©liore avec temps (data accumulation)

**PRD Action:** Spec rule-based algo Phase 1 + ML roadmap Phase 2

---

### 2. Growth Targets: **Conservateur + Scale Contingent** ‚úÖ

**Decision:** Brief garde targets conservateurs, pr√©parer scale narrative investors

**Internal Execution Plan (Brief actuel):**
- M1-3 Beta: 300-500 users, PMF validation
- M4-6: 6K-10K users, controlled growth
- M7-12: 10K-20K users, quality focus
- Priorit√©: Retention 18%+, NPS 50+, CAC:LTV 3:1+

**Investor Pitch (Contingent Scale):**
- **IF** PMF validated M6 (`Retention ‚â•20% AND NPS ‚â•55`)
- **THEN** accelerate M7-12: 30K-50K users avec capital raised
- **TAM**: 28-35M femmes cycles irr√©guliers (Flo user base)
- **Narrative**: "Phase 1 quality, Phase 2 scale si m√©triques explosent"

**Rationale (Mary):**
- 10K-20K = ex√©cutable, safe
- Investors veulent hockey stick ‚Üí montrer potentiel scale

**Next Step:** Cr√©er slide deck "Scale Scenario" pour fundraising

---

### 3. Actionable Recommendations: **Smart Push Notifications** ‚úÖ

**Decision:** Notifications push intelligentes (pas spam)

**UX Spec PRD:**

**Smart Notification Examples:**
```
‚òÅÔ∏è "√ânergie moyenne pr√©vue demain - Pr√©vois journ√©e douce?"
   [Oui, ajust√©] [Pas cette fois]

üí§ "Ton sommeil <7h amplifie fatigue cette phase"
   [Programmer rappel 22h] [Ignorer]

üèÉ "Phase haute √©nergie - Bon moment projets exigeants!"
   [Planifier t√¢che] [OK]
```

**Intelligence Rules (Pas Spam):**
- Max 1 notification/jour
- Timing contextu el: Matin (√©nergie pr√©vue), Soir (sommeil/repos)
- User control: Toggle categori√©s (pr√©dictions, bien-√™tre, rappels)
- Machine learning: Si user ignore 3x m√™me type ‚Üí stop cette cat√©gorie

**Trackable for KPI "50% follow":**
- Click notification ‚Üí Action taken (tap "Oui ajust√©", "Planifier", etc.)
- Metric: `(Actions taken) / (Notifications sent)` ‚â• 50%

**Rationale:**
- Garde engagement sans friction lourde
- Prouve recommendations actionnables (Core KPI)
- Diff√©rent de Flo/Clue (g√©n√©riques, spam)

**PRD Action:** Notification taxonomy, timing rules, ML tuning algorithm

---

### 4. Medical Export Go-To-Market: **Bottom-Up Viral Phase 1** ‚úÖ

**Decision:** Approche virale utilisatrice-driven, pas partnerships formels early

**Phase 1 Strategy (M1-6):**

**Export Flow:**
1. Sarah g√©n√®re PDF export (2 mois historique)
2. Sarah pr√©sente √† gyn√©co rdv SOPK
3. Gyn√©co: "Excellent! Continuez ce tracking"
4. Gyn√©co recommande ShifAI √† 2-3 autres patientes SOPK
5. **Viral loop** organiquement

**Format Phase 1:**
- Simple PDF bien design√© (Sally input)
- Charts: Cycles timeline, sympt√¥mes heatmap, corr√©lations
- Footer: "G√©n√©r√© par ShifAI - App sant√© cycles f√©minins"
- **Pas** integration EHR (trop complexe early)

**Target:**
- 7%+ utilisatrices g√©n√®rent export M3 Beta
- 50%+ exports partag√©s avec docteur
- 3-5 gyn√©cos "champions" identifi√©s organiquement

**Phase 2 Strategy (M7-12+):**
- Formal partnerships avec gyn√©cos champions
- Associations endo/SOPK (EndoFrance, etc.)
- HL7 FHIR structured data (optional)

**Rationale (John):**
- Minimise overhead Phase 1 (pas sales team)
- Teste value prop r√©el (doctors trouvent-ils utile?)
- Permet iteration format export based feedback

**PRD Action:** PDF export design spec, viral mechanics, doctor feedback surveys

---

### 5. Core KPIs Roadmap Priority: **S√©quentiel M1-12** ‚úÖ

**Decision:** Prioriser 5 Core KPIs s√©quentiellement (pas parall√®le)

**M1-3 (Beta - Onboarding):**
- üéØ **Priority #1:** Time to Quick Win ‚â§3j
- üéØ **Priority #2:** Retention D30 ‚â•18%
- Goal: Valider onboarding + engagement foundation

**M4-6 (Launch - Differentiation):**
- üéØ **Priority #3:** Time to Personalized Insight ‚â§14j
- üéØ **Priority #4:** Medical Export 7%+ generated
- Goal: Unlock unique value (ML insights + medical)

**M7-12 (Scale - Excellence):**
- üéØ **Priority #5:** Prediction Accuracy 70%+ (ML launch)
- üéØ **Supporting:** Recommendations Followed 50%+
- Goal: Competitive moat solidified

**Rationale (John):**
- 5 KPIs parall√®le = impossible optimize all
- Sequential = team focus clair chaque phase
- Each phase builds on previous (Quick Wins ‚Üí Personalized ‚Üí Accuracy)

**PRD Action:** Roadmap feature priorities aligned with KPI sequence

---

## üöÄ Immediate Next Steps (Pre-PRD)

### 1. Finalize Brief Produit ‚úÖ
- [x] Incorporate agent feedback decisions
- [x] Update frontmatter stepsCompleted: [1, 2, 3, 4]
- [x] Ready for stakeholder review

### 2. Create PRD (Product Requirements Document)
- [ ] Features Spec d√©taill√©:
  - Rule-based prediction algo Phase 1
  - Smart notifications taxonomy
  - Body Map douleur interactions
  - Medical export PDF design
- [ ] UX/UI Spec:
  - Widget "M√©t√©o Int√©rieure" mockups
  - Onboarding flow (Quick Win J1-J3)
  - Recommendations notification templates
- [ ] Success Metrics tracking implementation:
  - Analytics events mapping
  - Dashboards definition (daily/weekly/monthly)

### 3. Create Tech Spec / Architecture Document
- [ ] Stack selection (React Native vs Flutter vs Native)
- [ ] Privacy architecture (E2E encryption, local storage)
- [ ] ML roadmap:
  - Phase 1: Rule-based heuristics
  - Phase 2: ML model selection (LSTM? Transformer?)
  - Training data strategy (synthetic? partnerships?)
- [ ] Scalability plan (10K ‚Üí 100K users)
- [ ] Backend architecture (Firebase? Custom API?)

### 4. Optional: Investor Pitch Deck
- [ ] Scale scenario narrative (10K-20K ‚Üí 30K-50K contingent)
- [ ] Market sizing (‚Ç¨432.8M EU, 28-35M TAM cycles irr√©guliers)
- [ ] Competitive differentiation moats
- [ ] Team (if applicable)
- [ ] Financial projections (Phase 1 conservative, Phase 2 scale)

---

## üìã Open Questions for PRD Phase

### Product:
- [ ] Freemium paywall: Quand exactement? (J14? J30? Feature-based?)
- [ ] Premium features pr√©cis: Quels insights gratuit vs premium?
- [ ] Community / Forums in-app? (20% engagement KPI mentioned)

### Technical:
- [ ] ML training data: O√π sourcer? Combien n√©cessaire? Privacy compliance?
- [ ] On-device ML vs Cloud? (Privacy trade-offs)
- [ ] Offline-first? (Sarah zones sans r√©seau)

### Business:
- [ ] Pricing tiers: Seulement ‚Ç¨49/an? ou options mensuel/trimestriel?
- [ ] Partenariats associations endo/SOPK: Timing Phase 1 vs Phase 2?
- [ ] B2B2C cliniques: Explore M12+ ou focus B2C only early?

---

## üéØ Success Criteria Recap

**Beta PMF Validation (M3):**
```
‚úÖ D30 Retention ‚â•60%
‚úÖ NPS ‚â•50
‚úÖ Medical Export ‚â•7% generated
‚úÖ Quick Win delivered ‚â§3j pour 90%+ users
‚úÖ Rule-based accuracy ‚â•55-60%
‚Üí GO Launch France
```

**Launch Success (M12):**
```
‚úÖ 10K-20K Total Users
‚úÖ D30 Retention ‚â•18%
‚úÖ Time to Personalized ‚â§14j
‚úÖ Medical Export 10%+
‚úÖ NPS ‚â•50
‚úÖ Premium Conversion 7-10%
‚úÖ Prediction Accuracy ‚â•70% (ML users)
‚Üí VALIDATED Scale Phase 2 (or fundraise)
```

---

## üí° Key Learnings from Agent Review

**Mary (Analyst):**
> "Ce Brief est investment-grade. Metrics framework best-in-class."

**Action:** Use metrics rigor dans investor comms.

**John (PM):**
> "Brief dit QUOI, PRD devra clarifier COMMENT."

**Action:** PRD hyper-d√©taill√© features, pas assumptions.

**Sally (UX):**
> "Personas = vision empathique. Design pour Sarah/Lina, pas 'user 18-35'."

**Action:** Every UX decision r√©f√©rence persona quotes.

**Winston (Architect):**
> "IA personnalis√©e = faisable MAIS manage expectations marketing vs tech reality."

**Action:** Marketing copy = realistic ("apprend ton rythme" vs "pr√©cis J1").

---

**Document Created:** 2026-01-29  
**Status:** Decisions locked, ready for PRD phase  
**Next Milestone:** PRD Draft ‚Üí Team Review ‚Üí Dev Kick-off

---
